42 CFR § 476.93 - Opportunity to discuss proposed initial denial determination and changes as a result of a DRG validation.

---
identifier: "/us/cfr/t42/s476.93"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "42 CFR § 476.93 - Opportunity to discuss proposed initial denial determination and changes as a result of a DRG validation."
title_number: 42
title_name: "Public Health"
section_number: "476.93"
section_name: "Opportunity to discuss proposed initial denial determination and changes as a result of a DRG validation."
chapter_name: "CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "F"
subchapter_name: "QUALITY IMPROVEMENT ORGANIZATIONS"
part_number: "476"
part_name: "QUALITY IMPROVEMENT ORGANIZATION REVIEW"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "42 U.S.C. 1302 and 1395hh."
regulatory_source: "44 FR 32081, June 4, 1979, unless otherwise noted. Redesignated at 64 FR 66279, Nov. 24, 1999."
cfr_part: "476"
---


# 476.93 Opportunity to discuss proposed initial denial determination and changes as a result of a DRG validation.

Before a QIO reaches an initial denial determination or makes a change as a result of a DRG validation, it must—

(a) Promptly notify the provider or supplier and the patient's attending physician (or other attending health care practitioner) of the proposed determination or DRG change; and

(b) Afford an opportunity for the provider or supplier and the physician (or other attending health care practitioner) to discuss the matter with the QIO physician advisor and to explain the nature of the patient's need for health care services, including all factors which preclude treatment of the patient as an outpatient or in an alternative level of inpatient care.